Holen Sie sich die Stockscreener-App
6.65
1.37%
0.09
Handel nachbörslich:
6.68
0.03
+0.45%
Certara Inc Aktie (CERT) Neueste Nachrichten
Avoiding Lag: Real-Time Signals in (CERT) Movement - Stock Traders Daily
Certara at Barclays Healthcare Conference: Strategic Growth and AI Integration - Investing.com
Dixon Mitchell Investment Counsel Inc. Purchases Shares of 866,380 Certara, Inc. $CERT - MarketBeat
Certara at Leerink Conference: Strategic Moves Amid Challenges By Investing.com - Investing.com India
Certara at Leerink Conference: Strategic Moves Amid Challenges - Investing.com
Certara, Inc. (NASDAQ:CERT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
How Investors Are Reacting To Certara (CERT) FDA Acceptance Of Simcyp In Place Of Clinical Trials - Sahm
Assessing Certara (CERT) Valuation After FDA PBPK Milestone And Latest Earnings Guidance - Sahm
Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference - Yahoo Finance
Certara appoints Jon Resnick as new CEO; reaffirms FY25 outlook - MSN
Will Certara Inc. stock outperform international peers2025 EndofYear Setup & Short-Term Trading Alerts - Naître et grandir
CERTCertara Inc Stock Price and Quote - Finviz
Certara, Inc. (CERT): Analysts Assign Equal-Weight Rating Amid Price Stagnation - 富途牛牛
Certara (CERT) Downgraded to Equal-Weight by Barclays | CERT Sto - GuruFocus
Certara's (CERT) Equal Weight Rating Reiterated at Barclays - MarketBeat
Forecasting The Future: 7 Analyst Projections For Certara - Benzinga
Barclays downgrades Certara stock rating on turnaround concerns By Investing.com - Investing.com South Africa
Barclays downgrades Certara stock rating on turnaround concerns - Investing.com
Certara at TD Cowen Conference: Strategic Focus and AI Integration By Investing.com - Investing.com Canada
Certara at TD Cowen Conference: Strategic Focus and AI Integration - Investing.com UK
Certara (CERT) Gains FDA Acceptance for PBPK Modeling in Drug Ap - GuruFocus
Certara, Inc. (CERT) Stock Analysis: Exploring a 38% Potential Upside in Health Information Services - DirectorsTalk Interviews
CERT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Certara Simcyp® simulator results replace ten human trials for chronic myeloid leukemia (CML) therapy asciminib - marketscreener.com
Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - Bitget
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - The Manila Times
FDA accepts virtual-patient data so leukemia drug avoids 10 trials - Stock Titan
Certara, Inc. $CERT Stock Holdings Boosted by Roubaix Capital LLC - MarketBeat
Certara Earnings Call: Software Strength Amid Transition - The Globe and Mail
Certara (CERT) director granted 5,547 restricted stock units - Stock Titan
Certara (CERT) director Arjun Bedi submits initial Form 3 insider filing - Stock Titan
Certara (CERT) Is Up 9.6% After Calling 2026 a Transition Year With Slower Growth Guidance - simplywall.st
Assessing Certara (CERT) Valuation After Recent Share Price Volatility - Yahoo Finance
Discipline and Rules-Based Execution in CERT Response - Stock Traders Daily
A Look At Certara (CERT) Valuation After Earnings Miss And 2026 Outlook Reset - simplywall.st
Certara, Inc. Hits 52-Week Low at USD 6.04 Amid Market Struggles - Markets Mojo
Certara (NASDAQ:CERT) Trading 6.1% HigherHere's What Happened - MarketBeat
Certara (CERT) Faces Downgrade Amid Strategic Uncertainty - GuruFocus
Certara (NASDAQ:CERT) Given New $8.00 Price Target at Barclays - MarketBeat
Certara stock downgraded at Craig-Hallum on growth concerns By Investing.com - Investing.com Canada
Certara stock downgraded at Craig-Hallum on growth concerns - Investing.com
Certara (NASDAQ:CERT) Rating Lowered to "Hold" at Craig Hallum - MarketBeat
Certara to Participate in Upcoming Investor Conferences - The Manila Times
Drug development firm Certara lines up three March investor talks - Stock Titan
Morgan Stanley Cuts Price Target on Certara to $11 From $12, Keeps Equalweight Rating - marketscreener.com
Decoding Certara Inc (CERT): A Strategic SWOT Insight - GuruFocus
Certara Q4 2025 slides: services growth offsets software weakness By Investing.com - Investing.com Australia
Certara stock hits 52-week low at 6.26 USD By Investing.com - Investing.com Australia
Certara (NASDAQ:CERT) Issues Earnings Results - MarketBeat
Leerink Maintains Outperform on Certara, Inc. (CERT) Feb 26 2026 PT $10 - Meyka
Certara Inc reports results for the quarter ended December 31Earnings Summary - TradingView
TD Cowen cuts Certara stock price target on macro headwinds By Investing.com - Investing.com India
TD Cowen cuts Certara stock price target on macro headwinds - Investing.com
Leerink cuts Certara stock price target on weak bookings, guidance By Investing.com - Investing.com South Africa
Certara outlines flat to 4% 2026 revenue growth as new CEO signals operational overhaul and $10M cost avoidance - MSN
Leerink cuts Certara stock price target on weak bookings, guidance - Investing.com
0.79%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):